American Society of Clinical Oncology shared a post on LinkedIn:
“Research conducted by Dr. Dang Luu Hong Nguyen of the Medical Genetics Institute and presented at ASCOBT26 evaluated the clinical performance and feasibility of a multi-cancer early detection blood test in a real-world cohort across six Asian countries. ASCO expert Dr. Julian Hong breaks down what the early detection test shows in this latest Science in Seconds.”
Title: Real-world performance of a multimodal cell-free DNA multi-cancer early detection test in Asian populations.
Author: Dang Nguyen
Other articles about American Society of Clinical Oncology on OncoDaily.